Definitive Healthcare (DH)
(Delayed Data from NSDQ)
$3.93 USD
+0.05 (1.29%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $3.94 +0.01 (0.25%) 5:46 PM ET
3-Hold of 5 3
B Value A Growth B Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
DH 3.93 +0.05(1.29%)
Will DH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for DH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DH
Definitive Healthcare Corp. (DH) Beats Q1 Earnings and Revenue Estimates
New Strong Sell Stocks for March 4th
DH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Definitive Healthcare Corp. (DH) Q4 Earnings and Revenues Surpass Estimates
Magnite (MGNI) Matches Q4 Earnings Estimates
Intuit Q2 Earnings Surpass Estimates, Revenues Increase Y/Y
Other News for DH
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) | DH ...
Definitive Healthcare Q1 Review: Revenue Slumps, Structural Issues Surface, And A SELL Rating Sticks
Definitive Healthcare (DH) Grants Inducement Award to New Executive | DH Stock News
Definitive Healthcare reports inducement grants under Nasdaq listing rule
Definitive Healthcare reports inducement grants under Nasdaq listing rule